 - Visit 4 - End of Study: Day 85 4 Efficacy evaluations will be based on dermatological assessments in the clinic. The primary statistical analyses of interest are 1 the percent change from baseline to Week 12 in the number of inflamed papulespustules lesions and non-inflamed open and closed comedones lesions. In addition, patients will also be evaluated by the Investigator to determine Clinical Success or Clinical Failure at Week 12 